RF19 | PSUN349 Histone Eraser and Reader Targeting Epigenetic Inhibitors Are Effective in Pancreatic Neuroendocrine Tumours

BACKGROUND: The 5-year survival for metastatic pancreatic neuroendocrine tumours (PNETs) is <50%, and current therapies are not effective. Thus, there is an unmet clinical need for new therapies for patients with PNETs. PNETs frequently have mutations in chromatin remodelling genes, including in...

Descripción completa

Detalles Bibliográficos
Autores principales: Carmichael, James, Escoubet, Laure, Lines, Kate, Mavrommatis, Konstantinos, Mortensen, Deborah, Thakker, Rajesh V, Thakurta, Anjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629168/
http://dx.doi.org/10.1210/jendso/bvac150.1859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629168/
http://dx.doi.org/10.1210/jendso/bvac150.1859

Ejemplares similares